Very honoured to have received the #ESTRO Honorary Member Award at #ESTRO 2024!

DESTINY-Breast06 will be presented on 6/2 at #ASCO24 by my friend & mentor of many years G Curigliano MD PhD. The trial, announced to be positive, may have a major impact on treatment sequencing and on the definition of HER2. Set your alarm clocks early on Sunday, make sure not to miss it.

ESMO - Eur. Oncology Andres Cervantes Ann Partridge MD, MPH Rebecca Dent Toni Choueiri, MD Sumanta K. Pal, MD, FASCO Tom Powles silke gillessen George Pentheroudakis we welcome submissions for another exciting congress in Barcelona in September! Few hours left for submission deadline! OncoAlert Fred Hutchinson Cancer Center Dr. Tom Lynch

So proud of this project on 2 levels:
(1) It showcases the hard work of our superstar City of Hope fellow Hedyeh Ebrahimi
(2) It showcases OUTSTANDING mentorship from our junior faculty member Alex Chehrazi-Raffle, MD

In this piece (reflecting a collaboration w ACCC & Genentech), they…

Analysis of B7-H3 in >150,000 cancer samples from >50 histologies. A new therapeutic target is born. Congrats to Carly Miller on her first-author paper. Thanks also to Caris Life Services for their collaboration. aacrjournals.org/cancerrescommu…

HAPPY NURSES WEEK! A special thank you to all the nurses Dana-Farber; you all take such extraordinary care of patients, and we are so grateful for all that you do!

Dana-Farber’s Breast Oncology Center

Great to be Milken Institute Global Conference in Los Angeles!
 
On behalf of AstraZeneca, I participated in a panel discussion called The Next Wave of Immunotherapy & Cancer Treatment. Excited to connect with other industry and health leaders.
#MIGlobal

Today I am so happy to tweet my friend Stephen V Liu, MD who is doing a wonderful lesson and is a wonderful human being!

Join me and 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 as we host this wonderful line up of 🤩speakers to discuss updates in #cancer in #Nashville Sat 6/22/24. Summary - MLS Nashville (cvent.com). CODE: MLS100 #cancer research Vanderbilt-Ingram Cancer Center Dr. jordan berlin Christine Lovly, MD, PhD Oncology Brothers Matthew Villaume…

#HOPLive24 #HemOnc Pulse | Thanks 🙏 chadi nabhan MD, MBA, FACP & team for organizing a brilliant meeting. Honored to have had the chance to moderate our distinguished panel for #UnansweredQuestions in MPN with fantastic group 👏 Toyosi Odenike Ruben A. Mesa, MD Sanam Loghavi, MD صنم لغوی 🔬🧬 | #MPNSM

Petros Grivas working hard at the Amer. Urol. Assn. IBCG #AUA -IBCG Bladderca forum!
Glad to represent medoncs with him for this important session!
Ashish M. Kamat, MD, MBBS Roger Li Patrick Hensley, MD Zach Klaassen Sarah P. Psutka MD MS

Thank you! Tremendous honor to give the Donald S. Coffey Lecture at SUO/SBUR #AUA2024

#AUA24 Shilpa Gupta Avel 1L maintenance for aUC: Long-term outcomes from JAVELIN Bladder 100 in subgroups -- 1L chemo regimen and analysis of OS from start of 1L chemo UroToday.com

📍Overall pop: mOS from start 1L chemo - 29.7 mos for Avel + BSC vs 20.5 mos for BSC alone (HR 0.77,…

Next, Dr. McGregor is talking about VHL syndrome in ccRCC and clinical trials using Belzutifan #AUA24 #SUO #SBUR

6. Huge thanks to ACCC for conducting this study and to the cancer centers that participated in this project.

Forever grateful to my mentors Alex Chehrazi-Raffle, MD Sumanta K. Pal, MD, FASCO and our phenomenal research team City of Hope

5. ➡️Next phase of this study:
- Customizing training and admin support to ↑ accessibility, esp in regions historically with ↓ access to clinical trials.

3. While >90% of centers conducted research studies:
📉Phase 1 trials were offered less frequently than phase 2or3 trials
📉Phase 1 trials were offered more frequently at urban and ↑ volume centers
📉Industry-sponsored trials were more prevalent at academic and ↑ volume centers

2. Previous studies have shown most pts with cancer receive care at community centers & willing to participate in clinical trial.However <5% receive care within context of clinical trial. We assessed contributing factors in a national survey among 58 cancer centers from 25 states

1. Hot off the presses JAMA Network Open!

We assessed the unique challenges that community cancer centers face to engage in oncology clinical trials in collaboration with ACCC and @Genentech under the mentorship of Alex Chehrazi-Raffle, MD

jamanetwork.com/journals/jaman…